The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1976, 117: 1943-1948.
Copyright © 1976 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tompkins, W. A. F.
Right arrow Articles by Rawls, W. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tompkins, W. A. F.
Right arrow Articles by Rawls, W. E.

Specific Lysis of Human Colon Tumor Cells by Antibodies to CEA and Isoantigen A: Dependence on Rabbit Serum or Neuraminidase1

Wayne A. F. Tompkins2, Pradeep B. Seth3, Dick-Man Yip2, Jerry L. Palmer2, Sydney R. Gee3 and William E. Rawls3

Center for Zoonoses and Comparative Medicine, University of Illinois, College of Veterinary Medicine, Urbana, Illinois 61801, and the Department of Pathology, McMaster University, Hamilton, Ontario, Canada

Abstract

The 51Cr cytotoxicity test was used to measure specific antibody reactions against carcinoembryonic antigen (CEA) and isoantigen A on the surface of human colon tumor cells. When human serum or guinea pig serum was used as a source of complement, no anti-CEA or anti-isoantigen A cytotoxicity was demonstrable despite binding of specific antibodies and activation of complement at least through the C3 component on the cell surface. In contrast, specific anti-CEA and anti-isoantigen A cytotoxicity was demonstrated when rabbit serum was used as a source of complement. Specific antibody-mediated cell lysis was also achieved with guinea pig complement if the cells were treated with neuraminidase before testing. These results support the concept that certain tumor cells have surface properties that render them resistant to immune lysis.

Footnotes

1 This work was supported by a grant from the National Cancer Institute of Canada.

2 Center for Zoonoses and Comparative Medicine, University of Illinois, College of Veterinary Medicine, Urbana, Illinois 61801.

3 Department of Pathology, McMaster University, Hamilton, Ontario, Canada.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1976 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1976 by The American Association of Immunologists, Inc. All rights reserved.